AQC-Pattern Accordion-Collapse Accordion-Expand Agenda-Map CROs Consulting Download Email Fax Filter-Check Filter-Remove LinkedIn Map-Pin Member-Login Pharma-Biotech-Devices Phone Summit-Registration Survey-Research The-Avoca-Group-Consulting-And-Research-Services-Horizontal The-Avoca-Group-Diligent-Prequalification-Platform-Horizontal The-Avoca-Group-Quality-Consortium-Horizontal Training avoca-logo-coloravoca-logo-graycheckconsulting_logo2 diligent_logo2 dots dotted-01 dotted down-arrow GroupCreated with Sketch. minus plus quality_logo2 right-arrow twitter

Archives: News & Events

AQC 2023 Membership Pricing Updates

Today, the WCG Avoca Quality Consortium (AQC) is over 200 Member companies strong, representing Sponsors, CROs, Sites, and Clinical Service Providers of all sizes. To remain true to our mission of helping our Member organizations improve efficiency, increase quality, and ensure compliance in clinical trial execution, WCG Avoca will not be increasing AQC Annual Membership […]

Read More

AQC Vendor Days

September 7-8, 2022  |  10:00am – 3:00pm EDT
WCG Avoca is excited to offer our first-ever virtual Vendor Days event, during which AQC Vendor Members will showcase their solutions and engage in a group setting where insights and needs will be shared among attendees.

Read More

2021 Avoca Industry Report: Diversity in Clinical Research

Each year, WCG Avoca surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers.
Access The 2021 WCG Avoca State of the Industry Report: Diversity in Clinical Research Execution and Participation

Read More

Article: Diversity In Clinical Research Execution And Participation

Life Science Leader - By Denise Calaprice, Ph. D., Senior Consultant, WCG Avoca - The events of the past two years created an urgent and nonnegotiable imperative to increase diversity in clinical research: diversity both in how such studies are executed, and in the types of patients recruited for participation […]

Read More

Oracle Health Sciences Connect 2022

April - May 2022  |  Virtual
Join Oracle's global community of customer advocates and industry leaders virtually for in-depth discussions about overcoming the challenges of today’s life sciences environment.

Read More

2020 Avoca Industry Report: Innovation and Diversity

Each year, WCG Avoca surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers.
Access The 2020 Avoca State of the Industry Report: Innovation by Fire, Diversity, and the Next Normal

Read More

Article: How CRO-Sponsor Partnerships Spurred Innovation In 2020

Life Science Leader - By Denise Calaprice, Ph. D., Senior Consultant, WCG Avoca - For decades, operational progress within the clinical research industry has been profoundly shaped by the relationships between sponsor companies and their CRO partners. Among other advances, these relationships have contributed to sponsors’ abilities to globalize clinical trial operations, expand […]

Read More

News Release: WCG Acquires The Avoca Group

The Avoca Group strengthens WCG’s position as an industry leader for accelerating clinical trial quality management and compliance transformation. WCG™, a leading provider of clinical trial solutions, announced its acquisition of The Avoca Group, a life sciences consulting firm supporting biopharma, biotech, CROs and clinical service providers, […]

Read More

Quality Management System for a Clinical-Stage Biopharmaceutical Company

A clinical-stage biopharmaceutical company requested The Avoca Group perform an in-depth review and assessment of its Quality Management System (QMS). The project objectives were to identify and document gaps and to provide guidance in the design and development of a comprehensive QMS that would complement the company’s existing QMS. The company also requested that Avoca […]

Read More

SOP Review for a Clinical-Stage Biopharmaceutical Company

Since the release of ICH (E6) R2 in 2017, clinical research companies have been taking active measures to ensure compliance with its new guidance which, “encourages implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording, and reporting while continuing to ensure human subject protection and reliability of trial results.” In […]

Read More

CQMS Consulting Project for a Clinical-Stage Biopharmaceutical Company

A clinical-stage global biopharmaceutical company with major hubs in the US and Japan requested The Avoca Group perform an in-depth review and assessment of its Clinical Quality Management System (CQMS) with a special focus on Vendor Oversight, Risk Management, Technology Business Requirements, and Quality Tolerance Limits (QTLs). The project objectives were to identify and document […]

Read More

Not Just A Mock Inspection: With Storyboarding, WCG Avoca Gives Pharma Client the Insight and Tools for a Successful Regulatory Inspection

By providing a mid-sized pharmaceutical client with more than a standard mock inspection and having the agility to pivot as the client’s needs changed, WCG Avoca positioned the company for a successful regulatory inspection. WCG Avoca not only delivered clear and actionable findings; it helped the client design and execute a remediation strategy. To download […]

Read More

Mock Inspection Consulting Project for a Clinical-Stage Biopharmaceutical Company

As the GCP landscape continually evolves, sponsors are encouraged to pursue innovative approaches. Mock Inspections are a critical tool to ensure inspection readiness and a quality control step to confirm that the innovative approaches are being implemented in a regulatorily compliant way. Inspection Readiness needs to keep pace with this philosophy and to be proactive, […]

Read More

Standardized Metrics for Better Risk Management: The Right Data at the Right Time

August, 2016 Just because information can be gathered and shared more quickly among stakeholders does not mean that it can identify risk. This article describes the need for pharma to adopt fully-vetted, standardized operational-level time, cost and quality performance metrics as tools for tracking and predicting performance. The proliferation of cloud-based technologies has made it […]

Read More

Importance of Data Entry Timeliness

April 7, 2017 The pharma industry agrees that the importance of entering data into an EDC as soon as possible following a subject is paramount. Slow site data entry can impact the credibility and usefulness of centralized monitoring data analytic reports. But MCC survey indicates poor oversight undermines ability to monitor study quality With the […]

Read More

Finally, Standardized KPIs are Front and Center

June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.

Read More

Aligning Data Entry and Site Payment Incentives For Clinical Trials and Patients

June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.

Read More

Bridging the Gaps in CAPA Planning in Clinical Trials

June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.

Read More

Novo Nordisk Receives First Place in ACRP-Avoca Sponsor Quality Awards

Press Release – September 30, 2020 Novo Nordisk was recognized with the ACRP-Avoca Sponsor Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality Awards were announced: First Place – Novo Nordisk Second Place […]

Read More

Covance Receives First Place in ACRP-Avoca CRO Quality Awards

Press Release – September 30, 2020 Covance was recognized with the ACRP-Avoca CRO Quality Award during the ACRP-Avoca Quality Congress this month. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards were announced: First Place – Covance Second Place – ICON […]

Read More

2019 Avoca Industry Report: Quality Oversight

Each year, The Avoca Group surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers. Access The 2019 Avoca State of the Industry Report: Quality Oversight in Clinical Outsourcing

Read More

2019 Avoca Industry Report: Clinical Outsourcing

Each year, The Avoca Group surveys industry professionals to understand trends in clinical development, with a particular focus on outsourcing dynamics and relationships between research Sponsors and Providers. Access The 2019 Avoca State of the Industry Report: Clinical Outsourcing Spend & Key Relationship Measures

Read More

Article: How A Small Biotech Survived A Virtual Regulatory Inspection During COVID-19

July 7, 2020 – Clinical Leader – By Mai Nguyen, Senior Consultant, The Avoca Group – In clinical research, we learn to act instinctively and quickly when it comes to making decisions about subject protection, data validity, and ethical conduct. That skillset inherently comes with the ability for problem-solving with a focused determination on the patient. The […]

Read More

Article: Ask the Experts – Keeping Up with ICH E6 Changes

June 15, 2020 - CenterWatch
With the International Council on Harmonization (ICH) poised to begin work on another revision to its good clinical practice (GCP) guideline, ICH E6, sites and sponsors have questions about what they can expect from upcoming changes while they still are struggling to interpret requirements placed on them by the previous 2016 revision. See insights provided by Steve Whittaker, Senior Consultant of The Avoca Group.

Read More

Webinar: ICH E6(R3): How to prepare when you’re still struggling to adopt ICH E6(R2)

May 5, 2020  |  11:00am – 12:00pm EDT
The Final Concept Paper for ICH E6(R3), dated 17 November 2019, states, “The action proposed is a full rewrite and reorganization of the ICH E6(R2) Guideline….and will include addressing the application of GCP principles to the increasingly diverse trial types and the data sources being employed to support regulatory and healthcare-related decision-making on drugs, and provide flexibility whenever appropriate to facilitate the use of technological innovations in clinical trials.”

Read More

ACRP 2020: Signature Series (Postponed)

May 2, 2020 | Seattle, WA
Women in Leadership: Chutes, Ladders, and Unexpected Journeys - Executive leadership from Juno Therapeutics, Genentech, IQVIA, The Avoca Group, and Javara Research will share their career journeys and host an honest conversation about what it takes to advance as a woman in research.

Read More

ACRP-Avoca Quality Congress (Postponed)

May 1, 2020 | Seattle, WA
Adding Electricity to Patient Centricity: Energizing Solutions - Join patients and executive leadership from sponsors, CROs, sites, and technology suppliers in a collaborative, solutions-focused discussion of the patient centricity landscape. Industry leadership will unveil recent trends in the use of patient-centric tools and technologies and lead an […]

Read More

COVID-19 CEO Letter

March 25, 2020 – This is an update on how we are addressing the needs of Avoca’s clients and Quality Consortium Members, and the companies that we are working with as part of the Diligent® Qualification Platform, given the extraordinary circumstances that we face with COVID-19. The Avoca Group Operations Avoca and its global team of experts have […]

Read More

Article: Clinical Development Vendor Qualification: “Check-The-Box” Exercise?

March 4, 2020 – Contract Pharma – Jay A. Turpen, Senior Consultant, The Avoca Group – Key first steps to vendor risk management. Are your company’s clinical development vendor qualification (VQ) activities a “Check-The-Box” exercise because someone said that regulators expect it? Or are your VQ activities a comprehensive first step in managing the risk […]

Read More

Webinar: When Navigating Risk in Clinical Trials, It’s Best to Mind Your CTQs and QTLs

February 18, 2020 | 11:00am – 12:00pm EST
In this webinar, Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, will discuss the Quality Tolerance Limit requirements of ICH E6 (R2) and the intersect of Section 3 of ICH E8 (R1), where specific focus is given to proactive quality-by-design in clinical trials, including identifying and managing critical-to-quality factors (CTQs).

Read More

Webinar: Do You Have an Effective Oversight Plan of Your CRO-Vendor? How Are You Measuring It? ICH E6 R2 Requirements for Vendor Oversight

January 29, 2020 | 11:00am – 12:00pm EST
Sponsor Responsibilities for Quality Management (Section 5.0 of ICH E6 (R2)) requires that Sponsors oversee trial-related duties and functions, including those that are subcontracted by CROs (5.2.2). Quality assurance has changed from assurance of conformity to the assurance that process performance and quality are managed over […]

Read More

Virtual Clinical Trials Conference

December 2-3, 2019 | Sonesta Hotel | Philadelphia, PA Virtual clinical trials bring the clinical trial experience to the patient. Through these VCTs, companies are expected to reduce trial costs and increase patient enrollment and participation. There are new technologies that make these trials easier to conduct and with the patient demand for more flexibility in their participation, this new way of doing business will only continue to expand for the industry. […]

Read More

Article: The Spirit of Radical Integration

November 2019 In the Spotlight article published November 2019 by International Clinical Trials, Patricia (Patty) Leuchten, Founder and CEO of The Avoca Group, reflects on the challenges associated with managing risks and designing quality into clinical trials; the work the Avoca Quality Consortium® has done to bring together industry experts from pharma, biotech, and CROs […]

Read More

8th Annual AQC Fall Member Meeting

November 7, 2019 | Seattle, WA
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.

Read More

Webinar: Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?

October 29, 2019 | 1:00pm – 2:00pm EDT
Decentralized Clinical Trials (DCTs) offer a more patient-centric approach in which fewer clinic visits are required and patient and caregiver burden are reduced. DCTs utilize a wide range of digital technologies to collect safety and efficacy data from study participants, normally remotely from the patient’s own home. […]

Read More

ExL’s 10th Clinical Quality Oversight Forum

October 16-18, 2019  |  Sonesta Hotel  |  Philadelphia, PA The CQOF has become THE annual event for clinical quality professionals to network with, learn from and benchmark against their peers. The CQOF provides an interactive forum for senior-level clinical quality and operations professionals to engage, discuss and share their challenges, best practices and experiences in […]

Read More

Article: What Do Sponsors And CROs Think About Technology Use In Trials?

August 26, 2019 – ClinicalLeader.com – Ed Miseta, Chief Editor, Clinical Leader – Each year, The Avoca Group surveys industry professionals to understand trends in clinical development. The surveys place a particular focus on outsourcing dynamics and relationships between sponsor companies and service providers. For one of its most recent surveys, Avoca examined what sponsors and […]

Read More

ExL’s 8th Clinical Trials Inspection Readiness Summit

August 14-15, 2019  |  Sonesta Hotel  |  Philadelphia, PA The Avoca Group is pleased to once again be speaking at ExL’s 8th Clinical Trials Inspection Readiness Summit, August 14-15, in Philadelphia, PA. By attending the Summit, you will understand the importance of an organizational culture of inspection readiness and how to implement that cultural change. […]

Read More

T3: Tech, Trials and Transformation

August 8-9, 2019  |  The Inn at Penn  |  Philadelphia, PA Please join Avoca at T3: Trials, Tech and Transformation where we will be speaking and participating on a panel. T3 provides a platform to industry insights and patient perspectives on the major shifts occurring within the clinical trial space. By attending, you will gain insight […]

Read More

Webinar: Mock Inspections: A Critical Tool To Ensure Inspection Readiness

July 18, 2019 | 11:00am – 12:00pm EDT
Periodic screenings are an important part of inspection readiness. In this presentation, we’ll discuss the benefits of an ongoing state of inspection readiness throughout a trial, where hidden challenges lurk in an inspection, and how mock inspections can bring these issues to light.

Read More

DIA 2019 Global Annual Meeting

June 23-27, 2019  |  San Diego, CA   The DIA 2019 Global Annual Meeting brings together thousands of innovators from around the globe. Designed to drive insights into action by connecting key policy discussions to real-world knowledge that you need to do your job every day, your attendance will accelerate your growth and your organization’s […]

Read More

8th Annual Avoca Global Summit

June 5-6, 2019 | Boston, MA
With over a dozen interactive sessions and numerous networking opportunities, the Summit offered attendees a chance to connect, address challenges, engage with thought leaders, and influence global change. For a recap of the event, click Read More below.

Read More

News Release: Avoca Quality Consortium and Longboat Clinical Partner to Deliver Clinical Trial Site Quality Management System (QMS) Tools to Industry Sponsors

May 29, 2019 — Dublin, Ireland — AP News — Longboat Clinical is pleased to announce a new partnership with the Avoca Quality Consortium (AQC) to make an extensive suite of quality management tools available to hospitals and clinics participating in clinical studies. The AQC, a precompetitive collaborative comprised of nearly 100 pharma, biotech, CRO, and […]

Read More

Outsourcing in Clinical Trials East Coast 2019

May 21-22, 2019  |  King of Prussia, PA Arena International’s Outsourcing in Clinical Trials East Coast will be co-located with Clinical Technology and Data Management East Coast in King of Prussia for its 10th Annual event! The 2019 programme boasts a range of speakers. Through a variety of interactive session formats, the agenda focusses on […]

Read More

News Release: Tufts CSDD Study on the Vendor Qualification Process

Examines vendor qualification process, company experience managing this process and ways that it can be improved May 15, 2019 – Contract Pharma – The Center for the Study of Drug Development, an independent, academic, non-profit research group within Tufts University School of Medicine, in collaboration with the Avoca Group, is conducting a survey examining the vendor […]

Read More

CHI’s 8th Clinical Trials Innovation Summit

May 13-15, 2019  |  Boston, MA The Avoca Group is pleased to once again be speaking at CHI’s 8th Clinical Trials Innovation Summit, May 13-15, in Boston, MA. The Summit brings together 300+ leaders from across pharma, biotech and academia for the perfect blend of high quality presentations and intimate networking. Through case studies, interactive discussions […]

Read More

Roche/Genentech Receives First Place in ACRP-Avoca Sponsor Quality Awards

Press Release – April 13, 2019 Washington, DC – Roche/Genentech was recognized with the ACRP-Avoca Sponsor Quality Award yesterday during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2019 annual conference. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor […]

Read More

PPD Receives First Place in ACRP-Avoca CRO Quality Awards

Press Release – April 13, 2019 Washington, DC – PPD was recognized with the ACRP-Avoca CRO Quality Award yesterday during the ACRP Awards and Recognition Ceremony taking place at the ACRP 2019 annual conference in Nashville. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following […]

Read More

ACRP Quality Congress

April 12, 2019  |  The Omni Nashville Hotel  |  Nashville, TN   Quality and Risk Management through Industry Collaboration Back for its second year, the ACRP Quality Congress provides an unparalleled view of the changing clinical trial landscape and offers exclusive networking opportunities with management teams from sponsors, CROs, and sites. This half-day program will […]

Read More

Article: Biopharma Precompetitive Collaboration: Optimizing Clinical Trial Quality, Efficiency, and Excellence

By Steven B. Whittaker and Janis L. Hall, The Avoca Group ClinicalLeader.com – April 11, 2019   Developing new, innovative pharmaceutical agents to address global health needs is becoming more complex, challenging, and costly. As the industry attempts to adapt and gain value for patients, healthcare providers, and other stakeholders, technologies, digitization, real-world data, immediate […]

Read More

ExL’s 10th Proactive GCP Compliance

March 18-20, 2019  |  The Inn at Penn  |  Philadelphia, PA Now in its tenth year, ExL’s Proactive GCP Compliance conference continues to act as the annual forum for both senior-level clinical quality and clinical operations executives to gather, learn and discuss strategies to achieve and maintain global GCP compliance. Join us to learn how […]

Read More

ExL’s 3rd European Clinical Quality Oversight Forum

February 25-26, 2019  |  Hilton London Canary Wharf  |  London, UK The European Clinical Quality Oversight Forum in London is the ONLY European event dedicated to risk-based approaches for selecting, managing and monitoring clinical vendors and sites. This interactive event focuses on ensuring trial integrity by effectively assessing, optimising and managing the quality of clinical […]

Read More

ExL’s 8th Trial Master File Summit

January 22-24, 2019  |  Hilton Orlando Lake Buena Vista  |  Orlando, FL Learn more >> 15% off standard pricing rates using Discount Code AVOCAVIP   Join Avoca for the following session: Thursday, January 24 – 9:10am  |  Main Conference Day Two [Panel] Prepare for a TMF Inspection With a Quality Management System Manifest prioritization drivers […]

Read More

ExL’s 8th CROWN Congress

January 22-24, 2019  |  Hilton Orlando Lake Buena Vista  |  Orlando, FL CROWN provides a comprehensive education on the latest strategies, trends, tools, and technologies for optimizing clinical trials and enables you to make the connections necessary to streamline operations and advance. In 2019, the 8th Crown Congress will expand on last years conference by […]

Read More

Article: Taking Control Of Clinical Quality Tolerance Limits In Clinical Trials

By Steve Whittaker, Senior Consultant, The Avoca Group ClinicalLeader.com – January 8, 2019   The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) E6(R2) regulations have created a buzz within the industry regarding newly required expectations for quality tolerance limits (QTLs) when conducting good clinical practice (GCP) clinical trials. QTLs […]

Read More

Article: Embracing the present and owning the future in clinical trial execution

By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Outsourcing-Pharma.com – December 13, 2018   2018 was a pivotal year for the pharmaceutical industry and the execution of clinical trials. In November 2016, for the first time in more than 20 years, the ICH E6 Good Clinical Practice (GCP) Guideline was amended, and […]

Read More

Quality Tolerance Limits as Required by ICH E6(R2): Definitions and Requirements for “Fit-For-Purpose” Compliance, New Webinar Hosted by Xtalks

TORONTO, December 13, 2018 (Newswire.com) – Expectations for quality tolerance limits when conducting Good Clinical Practice (GCP) clinical trials in accordance with ICH E6(R2) have generated a buzz in the industry. Quality tolerance limits have historically been required for Good Manufacturing Practice (GMP) activities, inferring limits by which significant actions must be taken to ensure the manufactured product achieves quality and usability limits. With regulators now […]

Read More

7th Annual AQC Fall Member Meeting

October 30, 2018 | Princeton, NJ
Attendance at the Fall Member Meeting is one of many benefits of Membership of the Avoca Quality Consortium. Participants gain practical knowledge and experience in a casual, interactive learning environment.

Read More

News Release: The Avoca Group Joins BlueCloud Global Networking System

October 16, 2018 — BlueCloud by HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company founded by patient-survivors, and The Avoca Group, Inc., a life sciences consulting firm dedicated to improving quality and compliance in the clinical trial execution process, today announced its mutual collaboration […]

Read More

Article: New ICH Guidelines Address Industry Inefficiency

By Crissy MacDonald, PhD, Executive Director, Client Delivery, The Avoca Group Applied Clinical Trials – August 23, 2018   Although the pharmaceutical industry has always incorporated risk-based processes, the ICH E6 (R2) addendum now mandates that clinical trial operations also include risk-based approaches. Based on the latest research, and The Avoca Group’s experience helping companies […]

Read More

Clinical Trials: Not Broken, But In Need Of Repair

By Ed Miseta, Chief Editor, Clinical Leader Clinical Leader – July 9, 2018   We all know the days of Big Pharma companies launching billion-dollar blockbuster drugs are generally behind us. Today, novel new therapies are harder to bring to market. Trials are costly, take a long time to complete, and too many of them […]

Read More

DIA 2018

June 24-28, 2018 | Boston, MA
Attend a forum entitled, “Executives Respond to the State of the Industry Report on Risk Based Approaches in Clinical Trials: Opportunity or Threat?” led by Dennis Salotti, VP of Operations, The Avoca Group.

Read More

7th Annual AQC Global Quality Summit

13-14 June 2018 | Dublin, Ireland
Join your peers for two insightful days of high-quality analyses and discussions focused on transforming clinical trial execution. Avoca will also unveil two new technology platforms.

Read More

Announcing Speaker Lineup for the 7th Annual AQC® Global Quality Summit

Press Release – May 23, 2018 Princeton, NJ – The Avoca Group has announced the full speaker lineup for the 7th Annual AQC® Global Quality Summit, taking place 13-14 June 2018 in Dublin, Ireland. The theme for this year’s event – Embrace the Present. Own the Future. – focuses on today’s most innovative solutions for […]

Read More

Clinical Leader Forum

May 9-10, 2018 | Philadelphia, PA
Patricia Leuchten, CEO, The Avoca Group, will participate in a panel discussion with SCRS, ACRO, ACRP, and APCR on Wednesday, May 9.

Read More

Medpace Receives First Place in ACRP-Avoca CRO Quality Awards

Press Release – April 27, 2018 Medpace was recognized with the first-ever ACRP-Avoca CRO Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading CROs at the event. The following ACRP-Avoca CRO Quality Awards […]

Read More

Abbott Laboratories Receives First Place in ACRP-Avoca Sponsor Quality Awards

Press Release – April 27, 2018 Abbott Laboratories was recognized with the first-ever ACRP-Avoca Sponsor Quality Award today during the ACRP-Avoca Awards and Recognition Ceremony taking place at the ACRP 2018 annual meeting. The Association of Clinical Research Professionals and The Avoca Group jointly recognized leading sponsors at the event. The following ACRP-Avoca Sponsor Quality […]

Read More

2018 Quality Congress

April 27, 2018 | National Harbor, MD
In conjunction with the ACRP Annual Meeting and the Avoca Quality Consortium®, this one-day event will offer participants an unparalleled view of the changing clinical trial landscape and transformational approaches to improving clinical research quality.

Read More

AQC Member-only Webinar

March 21, 2018 | 11:00am - 12:00pm EDT
Inspection Preparation With a Risk-Based Approach Consistent with ICH E6 (R2) Requirements

Read More

9th Proactive GCP Compliance

March 19-21, 2018 | Philadelphia, PA
Join Avoca for a presentation outlining a practical approach for identifying and measuring risk in clinical trial operations.

Read More

Article: A Practical Framework For Assessing Risk In Clinical Trials

By Cristin MacDonald, PhD, Executive Director of Client Delivery, The Avoca Group Clinical Leader – March 15, 2018   The purpose of a comprehensive assessment system is to support structured, systematic, objective, and rational decision making. This holds true even when assessing something as difficult to pin down as risk. The Avoca Quality Consortium (AQC) takes […]

Read More

ACRP and The Avoca Group Announce Finalists for CRO and Sponsor Quality Awards

Press Release – March 13, 2018 The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP/Avoca Awards & Recognition Ceremony on Friday, April 27, during the ACRP 2018 annual meeting. Finalists for the ACRP-Avoca Quality Awards were chosen by investigational sites through a research […]

Read More

7th Annual CROWN Congress

January 23-25, 2018 | Philadelphia, PA
Join Avoca as we present sessions on a Clinical Quality Risk Management System (CQRMS) with Inovio and developing effective oversight strategies, and lead a panel discussion on outsourcing in clinical trials.

Read More

7th Trial Master File Summit

January 16-18, 2018 | Orlando, FL
Join Avoca for a presentation on Inspection Readiness co-presented by Steve Whittaker, Executive Director, The Avoca Quality Consortium®; and Grace Crawford, Vice President Clinical Quality and Compliance, MedImmune.

Read More

The Avoca Group Transforms the Clinical Trial Execution Process by Introducing a Data-Driven, Time-Saving Solution for Vendor Prequalification

Press Release – December 19, 2017   Princeton, NJ – The Avoca Group today announced a new platform to accelerate the prequalification of clinical service providers by leveraging analytics-driven technology and industry-leading standards to provide rapid, intelligent access to in-depth RFI questionnaires. The Diligent® Prequalification Platform furthers the work Avoca has become known for over […]

Read More

6th Annual AQC Fall Member Meeting

Wednesday, October 25, 2017 | New Brunswick, NJ
The AQC Fall Member Meeting is an opportunity for ClinOps, Quality, Pharmacovigilance, Clinical Research and Development, and Outsourcing professionals to connect with Avoca and industry thought leaders in a fun, casual, and interactive learning environment.

Read More

ExL Pharma’s 8th Clinical Quality Oversight Forum

October 11-13, 2017  |  Sheraton Philadelphia Downtown Hotel  |  Philadelphia, PA   Join The Avoca Group at ExL Pharma’s 8th Clinical Quality Oversight Forum.     Attend to hear our own Dennis Salotti, M.S., MBA, CCRA, Vice President, Operations, The Avoca Group give a State of the Industry on Evaluating the Results from The Avoca […]

Read More

Article: Patricia Leuchten, Founder and CEO, The Avoca Group, is guest columnist for Clinical Leader

August 17, 2017
The article entitled, “The Changing Landscape Of Clinical Trials: How Leaders Should Respond” addresses the changing landscape of clinical trials. Mergers and acquisitions, new players, the rapid proliferation of technology, increased patient advocacy, and new regulatory guidelines have added to the complexity of trials and burdened resource-strapped leaders with additional challenges and risks.

Read More

Article: Best Practice on Outsourcing Clinical Trials

Irish Medical Times interviews Patty Leuchten, founder and CEO of The Avoca Group August 15, 2017

June Shannon, writer for the Irish Medical Times, spoke with Patty Leuchten, founder and CEO of the Avoca Group, during recent AQC Summit in Dublin, about the growth in outsourcing clinical trials.

Read More

ACRP and The Avoca Group Announce Strategic Partnership to Drive Quality and Collaboration in Clinical Research

Press Release – August 8, 2017   The Association of Clinical Research Professionals (ACRP) and The Avoca Group today announce a new strategic partnership aimed at driving quality, standardization, and collaboration in clinical research. The Avoca Group, whose clients include top five pharmaceutical companies and global contract research organizations (CROs), is a driving force behind […]

Read More

ExL Pharma’s 6th Clinical Trials Inspection Readiness Summit

August 7-8, 2017  |  The Rittenhouse Hotel  |  Philadelphia, PA   Is your organization inspection ready?  Join Avoca at ExL Pharma’s 6th Clinical Trials Inspection Readiness Summit August 7-8.  Attend a presentation by Steve Whittaker, Executive Director, Avoca Quality Consortium, and learn how to interpret the requirements described by ICH GCP E6R2. Plan how to […]

Read More

Webinar: QMS and Inspection Readiness

Reviewing The Components Of Quality Management Systems And How They Affect Inspection Readiness Especially In The Context Of The New ICH E6 R2 Requirements Thursday, July 6, 2017  |  10:00 am EDT  |  1 hour   Click here to access the webinar recording and slides, and receive the AQC Leading Practice Quality Agreement   The […]

Read More

Webinar:  Best Practices for CRO Oversight

How an Oversight Capability Maturity Model and Automation Drive Speed and Quality of Clinical Trials Wednesday, June 28, 2017  |  1:00 pm EDT  |  1 hour   Click here to access the webinar slides and receive the AQC OCMM Model Summary   Please join Avoca and Comprehend for or an in-depth look at challenges and […]

Read More

DIA 2017 Annual Meeting

June 18-22, 2017 McCormick Place | Chicago, IL The DIA 2017 Annual Meeting is the largest, longest-running event in the life sciences industry designed to foster the international exchange of actionable insights to improve health globally through the advancement of lifesaving medicines and technologies. DIA 2017, themed “Driving Insights to Action,” will host more than […]

Read More

ACRP 2017 Meeting & Expo

April 28 – May 2, 2017 Washington State Convention Center | Seattle, WA See the future of clinical research at the ACRP Meeting & Expo. Learn from the influencers, innovators, and regulators driving change in clinical trial operations. You and your team will gain practical strategies to manage change, streamline operations, and minimize risk. Position […]

Read More

Partnerships in Clinical Trials Europe – November 2016

16-17 November 2016 Reed Messe Wien Congress Center, Vienna   Conference Day One – Wednesday, 16 November 2016 2:00pm:  Stream 2:  Patients as Partners – Patient Centricity should be at the Core of All Trials – Is this the case? Chair:  Patty Leuchten, President & CEO at The Avoca Group Panelists: Estrella Garcia, Head of […]

Read More